Zentalis Pharmaceuticals (ZNTL)'s 30-day implied volatility (IV30) was 87.6% at the close on November 10, 2026, up from 85.4% the day before, against a 52-week range of 52.5% to 184.5%. Its 20-day historical volatility was 84.1%.
Data as of November 10, 2026.